- Home
- CBFV vs CGEN Comparison
CBFV vs CGEN Comparison
Compare CBFV & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CBFV | CGEN |
|---|---|---|
| Founded | 1901 | 1993 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.9M | 148.7M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | CBFV | CGEN |
|---|---|---|
| Price | $35.66 | $1.68 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $35.50 | $4.00 |
| AVG Volume (30 Days) | 5.1K | ★ 295.0K |
| Earning Date | 01-27-2026 | 03-05-2026 |
| Dividend Yield | ★ 3.04% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.51 | N/A |
| Revenue | ★ $40,244,000.00 | $6,903,000.00 |
| Revenue This Year | $12.14 | N/A |
| Revenue Next Year | $14.91 | $164.92 |
| P/E Ratio | $72.36 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $26.01 | $1.13 |
| 52 Week High | $37.75 | $2.38 |
Technical Indicators
Market Signals| Indicator | CBFV | CGEN |
|---|---|---|
| Relative Strength Index (RSI) | 53.01 | 44.44 |
| Support Level | $34.41 | $1.63 |
| Resistance Level | $37.50 | $1.82 |
| Average True Range (ATR) | 0.52 | 0.09 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 62.57 | 25.56 |
Price Performance
Historical ComparisonAbout CBFV CB Financial Services Inc.
CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.
About CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.